The impact of MYD88 and PIM1 in mature large B-cell non-Hodgkin lymphomas: Defining element of their evolution and prognosis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.MYD88 and PIM1 mutations are linked to diffuse large B-cell lymphoma (DLBCL) development. Assessing these gene mutations and expressions may improve diagnosis and prognosis for advanced DLBCL patients.
Area Of Science
- Oncology
- Genetics
- Pathology
Background
- MYD88 and PIM1 genes are implicated in lymphoma development and oncogenic signaling.
- Understanding their role in mature large B-cell non-Hodgkin lymphomas is crucial for improving patient outcomes.
Purpose Of The Study
- To determine the frequency of MYD88 and PIM1 mutations and their gene expressions.
- To correlate these genetic factors with clinicopathological parameters in mature large B-cell lymphomas.
Main Methods
- Retrospective analysis of 50 mature large B-cell lymphoma cases over ten years.
- Real-time polymerase chain reaction for mutation detection.
- Immunohistochemistry for gene expression evaluation.
Main Results
- MYD88 immunopositivity in diffuse large B-cell lymphoma (DLBCL) correlates with non-germinal center B-cell origin.
- High lactate dehydrogenase and PIM1 mutations/expression are associated with negative prognostic factors.
- Eastern Cooperative Oncology Group performance status and international prognostic index score are independent risk factors for mortality and survival.
Conclusions
- MYD88 and PIM1 mutations may enhance diagnosis and prognosis in advanced DLBCL.
- Further research is needed to validate these findings in larger cohorts.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...